McKesson | MCK - Sales Revenues

Stock Price
843.20
Daily Change
11.99 1.44%
Monthly
2.22%
Yearly
40.58%
Q1 Forecast
805.61

McKesson reported $103.15B in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Acadia Healthcare USD 851.6M 17.6M Sep/2025
Align Technology USD 995.7M 14.3M Sep/2025
Cardinal Health USD 64B 3.8B Sep/2025
Centene USD 49.69B 950M Sep/2025
Charles River Laboratories USD 1000M 32.14M Sep/2025
Cigna USD 69.7B 2.5B Sep/2025
CVS Health USD 102.9B 3.99B Sep/2025
DaVita Healthcare Partners USD 3.42B 40M Sep/2025
Dentsply International USD 904M 32M Sep/2025
Elevance Health USD 49.3B 790M Dec/2025
Encompass Health USD 1.48B 20M Sep/2025
HCA USD 19.51B 350M Dec/2025
Henry Schein USD 3.34B 100M Sep/2025
Humana USD 32.65B 260M Sep/2025
IQVIA Holdings USD 4.1B 80M Sep/2025
J&J USD 24.6B 610M Dec/2025
Laboratory Of America USD 3.56B 30M Sep/2025
McKesson USD 103.15B 5.32B Sep/2025
Molina Healthcare USD 11.48B 50M Sep/2025
Owens Minor USD 697.26M 15.36M Sep/2025
Quest Diagnostics USD 2.82B 60M Sep/2025
Stryker USD 7.2B 1.14B Dec/2025
Tenet Healthcare USD 5.29B 20M Sep/2025
UnitedHealth USD 113.2B 0 Dec/2025
Universal Health Services USD 4.5B 220M Sep/2025